Cure CMD is thrilled to announce the 2018-2019 International Research Grant Awards for LAMA2-CMD!
Research projects focused on LAMA2 have been awarded to:
Prof. Francesco Muntoni for one year of funding to explore the role of modifier genes in a mild MDC1A case associated with a loss of function mutation.
Prof. Markus Ruegg for one year of funding to explore the efficiency for the treatment of LAMA2-CMD using linker proteins after disease onset.
Congratulations to the researchers!
LAMA2 community, we are honored to be able to support groundbreaking new discoveries related to your subtype. Your support over the last two years has made these grant awards possible!
For more information about our grant process and other projects funded, check out Cure CMD's Grant Portfolio.